tiprankstipranks
Trending News
More News >
Inhibrx Biosciences, Inc. (INBX)
NASDAQ:INBX
US Market

Compare Inhibrx Biosciences Inc (INBX) vs. Competitors

Compare
56 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Inhibrx Biosciences Inc
$85.32
$1.11B
-7.45
462.88%
Prothena
$8.81
$474.24M
-1.69
-40.07%
4 Buy
1 Hold
1 Sell
Moderate Buy
CytomX Therapeutics
$5.69
$964.09M
13.61
550.29%
6 Buy
0 Hold
0 Sell
Strong Buy
Humacyte
$1.00
$192.55M
-4.18
-78.88%
4 Buy
0 Hold
0 Sell
Strong Buy
Monte Rosa Therapeutics
$20.52
$1.56B
67.19
218.14%
8 Buy
0 Hold
0 Sell
Strong Buy
Candel Therapeutics
$5.84
$320.61M
-10.44
-16.09%
4 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
INBX
Inhibrx Biosciences Inc
76.27
63.55
499.61%
PRTA
Prothena
8.81
-4.63
-34.45%
CTMX
CytomX Therapeutics
5.69
4.85
577.38%
HUMA
Humacyte
1.00
-3.30
-76.81%
GLUE
Monte Rosa Therapeutics
20.52
14.01
215.21%
CADL
Candel Therapeutics
5.84
-1.31
-18.32%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts